131 related articles for article (PubMed ID: 35016422)
21. Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center.
Stein ME; Kuten A; Drumea K; Goldsher D; Tzuk-Shina Z
J Surg Oncol; 1999 Jul; 71(3):167-70. PubMed ID: 10404133
[TBL] [Abstract][Full Text] [Related]
22. Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study.
Ameri A; Poisson M; Chauveinc L; Chen QM; Delattre JY
J Neurooncol; 1997 Apr; 32(2):155-60. PubMed ID: 9120545
[TBL] [Abstract][Full Text] [Related]
23. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
24. Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors.
Bokstein F; Shpigel S; Blumenthal DT
Cancer; 2008 May; 112(10):2267-73. PubMed ID: 18327820
[TBL] [Abstract][Full Text] [Related]
25. [Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
Chauvergne J; Chinet-Charrot P; Stöckle E; Thomas L; Toulouse C
Bull Cancer; 1996 Apr; 83(4):315-23. PubMed ID: 8680083
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
27. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
Li DX; Chen XB
Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
[TBL] [Abstract][Full Text] [Related]
29. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
Radiother Oncol; 1999 Apr; 51(1):27-33. PubMed ID: 10386714
[TBL] [Abstract][Full Text] [Related]
30. Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
Cairo MS; Shen V; Krailo MD; Bauer M; Miser JS; Sato JK; Blatt J; Blazar BR; Frierdich S; Liu-Mares W; Reaman GH
J Pediatr Hematol Oncol; 2001 Jan; 23(1):30-8. PubMed ID: 11196267
[TBL] [Abstract][Full Text] [Related]
31. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
[TBL] [Abstract][Full Text] [Related]
32. Three conventional-drug combination (ifosfamide, carboplatin, etoposide--ICE regimen) in advanced non-small cell lung cancer (NSCLC).
Cuomo AM; Robustelli della Cuna FS; Baiardi P; Torazzo R; Preti P; Robustelli della Cuna G
J Chemother; 2001 Aug; 13(4):434-9. PubMed ID: 11589488
[TBL] [Abstract][Full Text] [Related]
33. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
34. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
[TBL] [Abstract][Full Text] [Related]
35. Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Khemapech N; Oranratanaphan S; Termrungruanglert W; Lertkhachonsuk R; Vasurattana A
Asian Pac J Cancer Prev; 2013; 14(3):2131-5. PubMed ID: 23679331
[TBL] [Abstract][Full Text] [Related]
36. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
37. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN; Smith A; Foreman N; Bouffet E
Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
[TBL] [Abstract][Full Text] [Related]
39. Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
Giglio P; Dhamne M; Hess KR; Gilbert MR; Groves MD; Levin VA; Kang SL; Ictech SE; Liu V; Colman H; Conrad CA; Loghin M; de Groot J; Yung WK; Puduvalli VK
Cancer; 2012 Jul; 118(14):3599-606. PubMed ID: 22086614
[TBL] [Abstract][Full Text] [Related]
40. Treatment of recurrent malignant supratentorial astrocytomas with carboplatin and etoposide combined with recombinant mutant human tumor necrosis factor-alpha.
Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Ikeda K; Soma G; Fukushima T
Anticancer Res; 2002; 22(4):2447-53. PubMed ID: 12174942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
